Stay updated with breaking news from Jinzij wu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ Gannex Pharma Co., Ltd. ("Gannex"), a wholly-owned company of Ascletis Pharma Inc. (HKEX:1672, "Ascletis") dedicated to the research and. ....
Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HANGZHOU and SHAOXING, China, Jan. 24, 2024 /PRNewswire/ Ascletis Pharma Inc. today announces dosing of the first patient in Phase III clinical trial of ASC40 for treatment of moderate to. ....
Up to 68.2% mean relative reduction in liver fat content from baseline in biopsy-confirmed non-alcoholic steatohepatitis patients receiving 12-week treatment of ASC41 tablet At Week 12, up to. ....
/PRNewswire/ Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces initiation of the Phase III clinical trial of fatty acid synthase (FASN). ....